The Top 10 Countries Investing the Most in Healthcare so far in 2026
A global ranking by absolute expenditure, with the policy drivers and future plans behind each country's spending
A Note on Methodology, Because This Ranking Gets Misreported Constantly
Most "biggest healthcare spenders" lists online rank countries by health spending as a share of GDP — a genuinely useful measure of national priority, but a completely different question from which countries are actually moving the most absolute dollars into healthcare each year. Afghanistan, Tuvalu, and Liberia all post some of the highest health-spending-to-GDP ratios in the world, but none of them come close to the top 10 by total dollars spent, because their economies are small. This article ranks by total current health expenditure — the WHO Global Health Expenditure Database's standard measure, combining public spending, mandatory social insurance, private insurance, and out-of-pocket payments — which is the figure that actually determines how much hospital capacity, workforce, technology, and pharmaceutical access a health system can fund in absolute terms.
One honest caveat before the ranking: internationally comparable total health expenditure data typically lags by one to two years, since it requires national accounts reconciliation across public and private sources. The figures below draw on the most recent WHO, OECD, and Eurostat data available, generally reflecting 2023–2024. The top few positions on this list are extremely stable and unlikely to reorder; the middle and lower positions (roughly ranks 6 through 10) are closer, more genuinely contested, and should be read as a well-sourced estimate rather than an exact, undisputed order.
1. United States — Approximately $4.9–5.1 Trillion
No other country is within striking distance of the United States on this measure, and it isn't close. US national health expenditure crossed $4.4 trillion in 2022 and has continued climbing since, consistently representing between roughly a third and 40% of all health spending on Earth despite the US accounting for a much smaller share of global population. At around 17% of GDP, the US spends nearly double the OECD average share, driven by a combination of high administrative overhead (studies estimate more than 30% of US healthcare spending goes to billing, insurance administration, and compliance rather than direct care), elevated pharmaceutical and hospital pricing relative to peer nations, and a large private-insurance-financed system layered on top of Medicare and Medicaid.
Why the spending, and what's next: An aging Baby Boomer population continues pushing Medicare enrollment and costs upward, and the rapid uptake of GLP-1 receptor agonist medications (semaglutide, tirzepatide) for diabetes and obesity has become a major and rapidly growing line item, triggering active policy debate over coverage and cost-sharing in 2026. On the policy side, Medicare drug price negotiation under the Inflation Reduction Act continues expanding to cover more medications each year, hospital price transparency rules are tightening, and there's sustained bipartisan interest in value-based care models intended to shift providers away from pure fee-for-service incentives — though none of these initiatives are expected to meaningfully close the spending gap with peer nations in the near term.
2. China — Approximately $1.2–1.4 Trillion
China is the clear and rapidly growing second-largest healthcare spender in absolute terms, even though its spending remains a comparatively modest 5–7% of GDP — a reflection of how large the underlying economy is rather than proportionally high health priority. China's global share of health expenditure was projected to roughly double between 2018 and 2028, from around 9% to as much as 16% of the world total, making it the fastest-growing major spender on this list by a wide margin.
Why the spending, and what's next: China faces one of the most severe demographic aging trajectories of any large economy, with its 60-and-over population set to expand dramatically over the next decade, placing sustained pressure on both acute care and long-term care capacity. The government's "Healthy China 2030" strategic framework continues driving investment into expanded basic medical insurance coverage, rural and lower-tier city hospital infrastructure, and a stated ambition toward greater domestic pharmaceutical and medical-device self-sufficiency — partly a public health goal, partly a response to geopolitical supply-chain concerns. China has also become the world's second-largest pharmaceutical market by sales, with projected 2026 medicine expenditure in the range of $190–220 billion, and continues investing heavily in AI-assisted diagnostics and hospital digitization as a way to stretch a healthcare workforce that hasn't grown as fast as demand.
3. Germany — Approximately $530–540 Billion (€492 Billion)
Germany is comfortably the largest healthcare spender in the European Union in absolute terms, and also carries the EU's highest health-spending-to-GDP ratio among large economies, at roughly 11.7–12.3%. Its Bismarck-model social insurance system, funded through compulsory contributions split between employers and employees, has historically supported a hospital-dense system with more acute beds per capita than most peer nations.
Why the spending, and what's next: Germany is in the middle of an ambitious and genuinely contentious hospital reform (Krankenhausreform), aimed at consolidating and specializing hospital services — shifting away from a historically fragmented model with many small, general-purpose hospitals toward fewer, larger centers with defined specialization tiers, a change intended to improve both care quality and cost efficiency but facing real political resistance from regions worried about losing local hospital access. In parallel, Germany continues rolling out its electronic patient record (elektronische Patientenakte) and e-prescription infrastructure as part of a broader digital health push, and — directly relevant to international recruitment — continues actively working to address a well-documented healthcare workforce shortage (Fachkräftemangel) through both domestic training expansion and structured international recruitment, including formal bilateral labor agreements with several source countries.
4. Japan — Approximately $450–500 Billion
Japan's total health expenditure sits at roughly 10.6% of GDP, translating to a total in the high hundreds of billions of dollars, financed through a universal social insurance system covering the entire population. Japan is a genuinely instructive outlier in the broader "does spending equal outcomes" conversation: it achieves the world's highest life expectancy (over 84 years) while spending a meaningfully smaller share of GDP on health than the US, Germany, or France.
Why the spending, and what's next: Japan is the world's most "super-aged" major economy, with more than 29% of its population already over 65 — a demographic reality that makes long-term care funding, not acute hospital care, the fastest-growing and most fiscally strained part of its health budget. Japan's national health insurance system faces well-documented long-run sustainability pressure as the working-age population funding it continues to shrink relative to the retired population drawing on it, and policy responses have increasingly centered on technology: Japan is one of the most aggressive adopters of healthcare robotics and AI-assisted care specifically to offset a shrinking care workforce, alongside incremental increases in patient cost-sharing and continued debate over raising the pension and insurance contribution age thresholds.
5. France — Approximately $350 Billion (€325 Billion)
France's total current healthcare expenditure sits among the highest in the world as a share of GDP — a figure Eurostat and OECD data have repeatedly placed at or near the top of major European economies — funded through France's own Bismarck-style social insurance system (Assurance Maladie) layered with substantial public-hospital infrastructure.
Why the spending, and what's next: France's most consequential recent healthcare investment is the Ségur de la Santé plan, a major post-COVID package that included substantial pay increases for hospital staff and significant capital investment into hospital infrastructure modernization, launched specifically in response to pandemic-exposed strain on the public hospital system. Alongside this, France continues grappling with "medical deserts" — regions, often rural, with severe shortages of general practitioners and specialists — and has been experimenting with incentive payments, streamlined licensing for internationally trained physicians, and expanded telemedicine access as partial responses to that specific, geographically uneven shortage.
6. United Kingdom — Approximately $300–330 Billion
The UK's total health expenditure, combining NHS spending across all four nations with private health spending, sits at roughly 10.7–11.4% of GDP depending on the measurement basis used, placing it solidly in the upper-middle tier of this ranking despite the NHS's high public profile globally. NHS England alone accounts for the large majority of this, with a budget exceeding £180 billion in recent fiscal years.
Why the spending, and what's next: Much of the UK's current health investment is aimed at reducing the elective care backlog that built up during and after the pandemic, alongside NHS England's long-term workforce plan, which explicitly commits to substantially expanding domestic medical and nursing training places over the coming decade while continuing meaningful international recruitment in the interim through the Health and Care Worker visa route. The New Hospital Programme continues (with well-documented delays and funding controversy) working through a pipeline of hospital rebuilding and modernization projects, and digital transformation — a unified NHS App, expanded electronic patient records, and AI-assisted diagnostic tools, particularly in radiology and pathology — represents one of the more consistently prioritized investment areas across recent government spending reviews.
7. Canada — Approximately $250 Billion
Canada's total health expenditure runs at roughly 11.5% of GDP, funded through its provincially-administered, federally-supported single-payer Medicare system (distinct from the US program of the same name), placing it just above the OECD average as a share of GDP despite persistent domestic debate over system capacity and wait times.
Why the spending, and what's next: Much of Canada's recent healthcare investment growth traces to renewed federal-provincial health funding agreements negotiated in recent years, which came with explicit conditions around data-sharing, primary care access expansion, and mental health service investment. Canada has also been rolling out a new national dental care program extending coverage to lower- and middle-income Canadians who previously had no dental coverage, a genuinely significant new spending category layered onto the existing system. Separately, Canada's historically strong immigration-driven population growth has placed real strain on primary care capacity in several provinces, a factor directly feeding into the aggressive healthcare-specific immigration streams — including category-based Express Entry draws and province-specific nomination programs — that have made Canada one of the more actively recruiting destinations for internationally trained clinicians in recent years.
8. Brazil — Approximately $200–215 Billion
Brazil's total health expenditure runs at close to 9.6–10% of GDP, a genuinely high share for an economy at Brazil's income level, reflecting its constitutionally guaranteed universal public health system, the Sistema Único de Saúde (SUS) — one of the largest universal public health systems in the world by population covered.
Why the spending, and what's next: Brazil continues investing in expanding SUS primary care coverage into underserved regions, including continued iterations of the Mais Médicos (More Doctors) program, originally built around bringing in internationally trained physicians — including a historically significant Cuban medical cooperation component — to serve remote and underserved areas where domestically trained doctors have been reluctant to work. Brazil has also been investing meaningfully in domestic vaccine and pharmaceutical production capacity, partly a public-health resilience response following pandemic-era supply disruptions, alongside continued expansion of digital health records intended to better connect Brazil's large and historically fragmented public and private health sectors.
9. Italy — Approximately $195 Billion (€179 Billion)
Italy's total health expenditure sits at a comparatively modest 8.4–8.8% of GDP relative to other large European economies — among the lowest shares in the G7 — funded through its regionally-administered national health service, the Servizio Sanitario Nazionale.
Why the spending, and what's next: Italy's most significant current healthcare investment is tied directly to its allocation from the EU's post-pandemic Recovery and Resilience Facility (Italy's PNRR), which includes a specific, substantial healthcare component aimed at expanding community-based and territorial health services, upgrading digital health infrastructure, and — directly addressing one of Italy's longest-standing structural problems — narrowing the persistent quality and access gap between Italy's wealthier northern regions and its historically underserved south. Italy also faces a well-documented physician and nursing workforce shortage driven partly by an aging existing workforce approaching retirement and partly by continued outward migration of younger Italian-trained clinicians to higher-paying destinations elsewhere in Europe, a dynamic that has pushed several Italian regions toward more active international recruitment than has historically been typical for the country.
10. India — Approximately $170–200 Billion (Rapidly Rising)
India rounds out this ranking as the fastest-rising entrant among the group, even though its health spending remains a comparatively low share of GDP — public health expenditure alone is projected at under 2% of GDP for FY26, with total health spending (including India's very large private and out-of-pocket sector) considerably higher but still modest by international per-capita standards. What earns India a place on this list by absolute total is the sheer scale of its economy and population: India's total health spending, though small per person, aggregates to a genuinely large absolute figure and has been growing faster in percentage terms than almost any other country on this list.
Why the spending, and what's next: India's central government health budget continues rising annually — the FY26 Union Budget allocated roughly $12 billion to the Ministry of Health and Family Welfare alone, with the great majority directed toward the National Health Mission and the Ayushman Bharat universal health insurance scheme, which extends coverage to hundreds of millions of previously uninsured lower-income citizens. The Ayushman Bharat Digital Mission continues building out India's national digital health ecosystem, including interoperable electronic health records and a unique health ID system, intended to modernize a historically fragmented public-private health landscape. India's hospital and medical education capacity is also expanding rapidly, both to meet rising domestic demand and to support India's large and growing role as a global medical tourism and pharmaceutical manufacturing hub — India remains one of the world's largest suppliers of generic medications, a role its government continues actively investing in expanding.
What the Pattern Across These 10 Countries Actually Shows
A few themes recur clearly across every country on this list, regardless of income level, health system model, or region:
Aging populations are the dominant cost driver almost everywhere except India. The US, China, Germany, Japan, France, the UK, Canada, and Italy are all managing some version of the same underlying pressure — a shrinking working-age population funding healthcare for a growing retired population — and it shows up directly in where new spending is being directed, from Japan's long-term care system to Germany's hospital consolidation reform.
Digital health and AI-assisted care are treated as genuine cost-containment strategies, not just innovation for its own sake, particularly in Japan, China, the UK, and Brazil, where workforce shortages are pushing health systems toward technology as a way to extend limited clinical staff capacity rather than purely as a patient-experience upgrade.
Nearly every country on this list is simultaneously a source of international workforce competition for the others. Canada, the UK, and Germany are actively recruiting internationally to fill gaps their own training pipelines can't fill fast enough; Italy is increasingly losing its own trained clinicians to exactly these destinations; France and Brazil have each built specific programs (streamlined licensing pathways, the Mais Médicos initiative) around bringing internationally trained clinicians into underserved regions their domestic workforce won't reach. For an organization operating in international medical recruitment, this list isn't just a spending ranking — it's close to a map of where the demand side of the global clinician market is concentrated, and why.
Conclusion
Ranking countries by absolute healthcare spending tells a genuinely different story than the more commonly cited GDP-share rankings — it's a story dominated by the sheer scale of the US and China, followed by a tightly bunched group of large, aging, high-income economies each managing remarkably similar demographic pressure through different policy tools, with India rising fast enough to be a serious contender for this list's lower rungs within the next decade. Every country here is investing not just to maintain current care levels but specifically to address workforce shortages, aging populations, and digital modernization — three pressures that, not coincidentally, are also the three biggest drivers of the international medical recruitment market this publication covers regularly.
Sources
WHO Global Health Expenditure Database (current health expenditure, most recent available year by country)
Eurostat, "Healthcare expenditure statistics — overview" (data extracted October 2025)
OECD, "Health at a Glance 2025"
Statista, "Share of global health expenditure in 2018 and 2028 forecast, by country"
Statista, "U.S. national health expenditure 1960–2023" and related US health expenditure topic pages
CDC/NCHS, "Health Expenditures" fact sheet
World Health Systems Facts, "Japan: Health System Expenditures"
economicsbydesign.com, "Health Expenditure Explained: Who Pays, Where It Goes, and How Countries Vary" (ONS/OECD sourced, 2024–2025)
IBEF, "Healthcare Industry in India" and India Union Budget FY26 health allocation coverage
PRS Legislative Research, "Demand for Grants 2023-24 Analysis: Health and Family Welfare"
Healthcare IT News, "India lowers 2024 budget for digital health and more briefs"
Statista, "Projected spending on medicine of selected countries worldwide in 2026" (IQVIA data)
statisticsoftheworld.com, "Health Spending by Country 2026"
worldpopulationreview.com, "Healthcare Spending by Country 2026"